4 stories mentioning TYGOUpdated 40d ago
Every FINWIRES story that references TYGO, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Tigo Energy (TYGO) shares fell 4.9% on Wednesday after Roth Capital downgraded the stock to neutral from buy and cut its price target to $1.30 per share from $7.Trading volume stood at nearly 1.1 million shares compared with a daily average of close to 1.4 million.Price: $1.19, Change: $-0.07, Percent Change: -5.20%
Tigo Energy (TYGO) shares sank 38% after the company reported late Tuesday a plunge in Q2 adjusted earnings before interest, tax, depreciation, and amortization, and revenue growth that lagged its expectations.More than 8.7 million shares of the company traded intraday on Wednesday compared with a daily average of about 1.16 million.USANA Health Sciences (USNA) reported a year-over-year decline in net sales and swung to an adjusted diluted loss per share in Q2.Shares slumped 35% as intraday trading volume climbed to over 504,000 from the stock's daily average of about 113,000.SpaceX (SPCX) reported Q2 capital expenditures of $18.37 billion, up from $2.83 billion a year ago, taking the shine off a narrower-than-expected loss and above-consensus revenue growth.Shares declined 13%, with intraday trading volume rising to over 145.6 million from a daily average of about 110.3 million.Price: $1.27, Change: $-0.78, Percent Change: -37.99%
Autonomix Medical (AMIX) stock was down more than 41% premarket Wednesday after a 434% rise at the previous close.The Marygold (MGLD) shares were more than 33% lower, extending the nearly 6% loss from the prior session.China SXT Pharmaceuticals (SXTC) stock was down more than 31%, partially reversing the 60% rise at the previous close.Vivos Therapeutics (VVOS) shares were 30% lower pre-bell following a nearly 10% rise at Tuesday's close.Tigo Energy (TYGO) stock was down 25%, a day after the company posted Q2 financial results.
